title: The interplay of sociodemographic factors on virologic suppression among a U.S. outpatient HIV clinic population.
abstract: Understanding challenges to virologic suppression is essential to optimizing health outcomes among individuals with HIV. This cross-sectional behavioral assessment was conducted among 514 individuals presenting at an urban U.S. HIV clinic between June and September 2007. The majority of the sample was African American and male, with a mean age of 42 years. Most of the sample was receiving highly active antiretroviral therapy (HAART), and the majority of those had suppressed viral loads (HIV viral loads less than 400 copies per milliliter). By logistic regression analyses, African American/other minorities had 2.9 increased odds, those less than high school degree had 2.3 increased odds, those who were receiving ritonavir-boosted protease inhibitor therapy had 1.4 increased odds, and those who had expressed symptoms indicative of depressive disorders had 2.5 increased odds of having unsuppressed viremia as compared to Caucasians, those with more education, receiving non-nucleoside reverse transcriptase inhibitor-based therapy, and who had minimal depressive symptoms, respectively. These findings signify the importance of individualized interventions to enhance virologic suppression, both based on medication choices and individual characteristics.
authors.affiliation: Health Communication Research Laboratory, George Warren Brown School of Social Work, Washington University, St. Louis, Missouri 63112-1408, USA. eshacham@wustl.edu
authors.forename: Enbal
authors.initials: E
authors.lastname: Shacham
authors.forename: Diana
authors.initials: D
authors.lastname: Nurutdinova
authors.forename: Nur
authors.initials: N
authors.lastname: Onen
authors.forename: Katelin
authors.initials: K
authors.lastname: Stamm
authors.forename: E Turner
authors.initials: ET
authors.lastname: Overton
mesh_terms: D000293:Adolescent; D000328:Adult; D000554:Ambulatory Care Facilities; D019380:Anti-HIV Agents / Q000494:pharmacology / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D018791:CD4 Lymphocyte Count; D003430:Cross-Sectional Studies; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000191:economics / Q000208:ethnology / Q000821:virology*; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D008923:Missouri; D010349:Patient Compliance; D012307:Risk Factors; D012923:Social Class; D012959:Socioeconomic Factors; D014505:Urban Population; D019562:Viral Load; D014766:Viremia / Q000188:drug therapy* / Q000821:virology; D055815:Young Adult
chemical_list: D019380:Anti-HIV Agents
references.citation: Clin Infect Dis. 2006 Oct 1;43(7):939-41
references.pmid: 16941380
references.citation: JAMA. 2001 Mar 21;285(11):1466-74
references.pmid: 11255423
references.citation: Am J Public Health. 2001 Sep;91(9):1474-81
references.pmid: 11527784
references.citation: J Acquir Immune Defic Syndr. 2004 Dec 1;37(4):1470-6
references.pmid: 15602125
references.citation: J Epidemiol Community Health. 2008 Sep;62(9):798-803
references.pmid: 18701730
references.citation: J Gen Intern Med. 2004 Nov;19(11):1146-53
references.pmid: 15566445
references.citation: Contraception. 2008 Aug;78(2):125-30
references.pmid: 18672113
references.citation: AIDS Behav. 2006 May;10(3):253-61
references.pmid: 16482405
references.citation: AIDS Patient Care STDS. 2008 May;22(5):413-21
references.pmid: 18500922
references.citation: Am J Med. 2003 May;114(7):573-80
references.pmid: 12753881
references.citation: AIDS. 2006 Jan 9;20(2):223-31
references.pmid: 16511415
references.citation: J Acquir Immune Defic Syndr. 2009 Apr 15;50(5):529-36
references.pmid: 19223785
references.citation: N Engl J Med. 1998 Mar 26;338(13):853-60
references.pmid: 9516219
references.citation: AIDS Care. 2000 Jun;12(3):255-66
references.pmid: 10928201
references.citation: Psychosom Med. 2008 Jun;70(5):539-45
references.pmid: 18519880
references.citation: Lancet Infect Dis. 2007 Jan;7(1):5-6
references.pmid: 17182336
references.citation: J Acquir Immune Defic Syndr. 2006 Jul;42(3):298-306
references.pmid: 16639343
references.citation: HIV Med. 2006 Oct;7(7):437-41
references.pmid: 16925729
references.citation: J Gen Intern Med. 2004 Apr;19(4):366-74
references.pmid: 15061746
references.citation: J Womens Health (Larchmt). 2006 Mar;15(2):173-81
references.pmid: 16536681
references.citation: J Acquir Immune Defic Syndr. 2009 Jan 1;50(1):100-8
references.pmid: 19295340
references.citation: AIDS Patient Care STDS. 2009 Nov;23(11):949-55
references.pmid: 19925308
references.citation: Am J Public Health. 2002 Apr;92(4):624-31
references.pmid: 11919063
references.citation: South Med J. 2007 Aug;100(8):775-81
references.pmid: 17713302
references.citation: Science. 2008 May 9;320(5877):760-4
references.pmid: 18467582
references.citation: MMWR Recomm Rep. 2003 Jul 18;52(RR-12):1-24
references.pmid: 12875251
references.citation: Appl Nurs Res. 2001 Feb;14(1):3-10
references.pmid: 11172224
references.citation: J Acquir Immune Defic Syndr. 2008 Mar 1;47 Suppl 1:S15-9
references.pmid: 18301129
references.citation: J Antimicrob Chemother. 2004 May;53(5):696-9
references.pmid: 15044425
references.citation: Am J Public Health. 2006 Jun;96(6):1044-51
references.pmid: 16670232
references.citation: Clin Infect Dis. 2007 Jun 1;44(11):1493-9
references.pmid: 17479948
references.citation: AIDS Patient Care STDS. 2006 May;20(5):335-49
references.pmid: 16706708
references.citation: Am J Med. 2005 Aug;118(8):890-8
references.pmid: 16084183
references.citation: Ann Intern Med. 2000 Jul 4;133(1):21-30
references.pmid: 10877736
references.citation: AIDS Care. 1996 Jun;8(3):261-9
references.pmid: 8827119
references.citation: J Gen Intern Med. 2001 Sep;16(9):606-13
references.pmid: 11556941
references.citation: J Acquir Immune Defic Syndr. 2003 Apr 1;32(4):399-405
references.pmid: 12640198
references.citation: Am J Public Health. 2001 Jul;91(7):1019-24
references.pmid: 11441723
references.citation: J Acquir Immune Defic Syndr. 2005 Jan 1;38(1):96-103
references.pmid: 15608532